- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it will hold a conference call and webcast on Thursday August 14, 2008 at 8:00 am Pacific Time (11:00 am Eastern Time) to discuss second quarter 2008 operating results and to provide an update on developments at the Company.
About the Conference Call
To participate in the conference call, please dial 416-641-6139 or 1-866-299-6657. The call will be available for replay until August 28, 2008 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3268488.
The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com.
About Tekmira Pharmaceuticals Corporation
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi products and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
For more information, please click here
Tekmira Pharmaceuticals Corporation - Investors
Ian Mortimer, Vice President,
Executive Finance and Chief Financial Officer
Longview Communications Inc. - Media
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Arrowhead to Webcast Fiscal 2015 Year End Results December 7th, 2015
Haydale Announce Year End Results November 3rd, 2015
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016